Medicure (MCUJF) Liabilities and Shareholders Equity (2009 - 2026)

Medicure's Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $17.0 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity fell 17.85% year-over-year to $17.0 million; the TTM figure through Mar 2026 stood at $74.9 million (down 10.38% YoY), while the FY2025 annual figure was $17.9 million, down 15.79% from the prior year.
• Liabilities and Shareholders Equity was $17.0 million for Q1 2026 at Medicure, down from $17.9 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $23.5 million in Q2 2022 to a low of $17.0 million in Q1 2026.
• Historically, Liabilities and Shareholders Equity has averaged $20.9 million across 5 years, with a median of $21.1 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Liabilities and Shareholders Equity advanced 3.08% in 2024, then slipped 17.85% in 2026.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $22.0 million in 2022, then slipped by 6.43% to $20.6 million in 2023, then gained by 3.08% to $21.2 million in 2024, then decreased by 15.79% to $17.9 million in 2025, then declined by 4.71% to $17.0 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $17.0 million (Q1 2026), $17.9 million (Q4 2025), and $19.4 million (Q3 2025), per Business Quant data.